INTELLECTUAL CAPITAL TERHADAP KINERJA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2009-2017 indonesia

Abstract

This purpose of this research is to analyze the impact of intellectual
capital on the companies performance. The research used quantitative
approach, and it collected by annual reports to pharmaceutical company at
Indonesia Stock Exchange (IDX) from year 2009–2017 which had a population
of 10 companies. The hypothesis of this research is tested by using
multiple regression analysis. The result indicate that (1) intellectual capital
has positive influence to the companies performance (ROA and ROE); (2)
intellectual capital has negative influence on companies performance (ATO
and MBV). Hence, to maximize the performance on pharmaceutical companies
merely consider intellectual capital factors.